Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins (original) (raw)

• Clarke JB. Mechanisms of adverse drug reactions to biologics. Handb Exp Pharmacol. 2010;196:453–74.
  Article PubMed CAS Google Scholar
• Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, et al. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study. Ann Rheum Dis. 2010;69(5):817–21.
  Article PubMed CAS Google Scholar
• Bertolotto A, Deisenhammer F, Gallo P, Sölberg Sørensen P. Immunogenicity of interferon beta: differences among products. J Neurol. 2004;251 Suppl 2:II15–24.
  PubMed Google Scholar
• De Vries MK, Brouwer E, van der Horst-Bruinsma IE, Spoorenberg A, van Denderen JC, Jamnitski A, et al. Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation. Ann Rheum Dis. 2009;68(11):1787–8.
  Article PubMed Google Scholar
• Schellekens H. Immunologic mechanisms of EPO-associated pure red cell aplasia. Best Pract Res Clin Haematol. 2005;18(3):473–80.
  Article PubMed CAS Google Scholar
• McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, et al. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008;48(8):1754–62.
  Article PubMed Google Scholar
• Yang J, Joo KW, Kim YS, Ahn C, Han JS, Kim S, et al. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies. J Nephrol. 2005;18(1):102–5.
  PubMed Google Scholar
• Brinks V, Jiskoot W, Schellekens H. Immunogenicity of therapeutic proteins: the use of animal models. Pharm Res. 2011;28(10):2379–85.
  Article PubMed CAS Google Scholar
• Bryson CJ, Jones TD, Baker MP. Prediction of immunogenicity of therapeutic proteins: validity of computational tools. BioDrugs. 2010;24(1):1–8.
  Article PubMed CAS Google Scholar
• Wullner D, Zhou L, Bramhall E, Kuck A, Goletz TJ, Swanson S, et al. Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics. Clin Immunol. 2010;137(1):5–14.
  Article PubMed CAS Google Scholar
• Schellekens H. How to predict and prevent the immunogenicity of therapeutic proteins. Biotechnol Annu Rev. 2008;14:191–202.
  Article PubMed CAS Google Scholar
• Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant. 2005;20 Suppl 6:vi3–9.
  Article PubMed CAS Google Scholar
• Stas P, Lasters I. Strategies for preclinical immunogenicity assessment of protein therapeutics. IDrugs. 2009;12(3):169–73.
  PubMed CAS Google Scholar
• De Groot AS, Knopp PM, Martin W. De-immunization of therapeutic proteins by T-cell epitope modification. Dev Biol (Basel). 2005;122:171–94.
  Google Scholar
• Perry LCA, Jones TD, Baker MP. New approaches to prediction of immune responses to therapeutic proteins during preclinical development. Drugs R D. 2008;9(6):385–96.
  Article PubMed CAS Google Scholar
• Baker MP, Reynolds HM, Lumicisi B, Bryson CJ. Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self Nonself. 2010;1(4):314–22.
  Article PubMed Google Scholar
• Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods. 2004;34(4):468–75.
  Article PubMed CAS Google Scholar
• De Groot AS, Jesdale BM, Szu E, Schafer JR, Chicz RM, Deocampo G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retrovir. 1997;13(7):529–31.
  Article PubMed Google Scholar
• Dönnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res. 2006;34(Web Server issue):W194–7.
  Article PubMed Google Scholar
• Van Walle I, Gansemans Y, Parren PWHI, Stas P, Lasters I. Immunogenicity screening in protein drug development. Expert Opin Biol Ther. 2007;7(3):405–18.
  Article PubMed Google Scholar
• Lata S, Bhasin M, Raghava GPS. Application of machine learning techniques in predicting MHC binders. Methods Mol Biol. 2007;409:201–15.
  Article PubMed CAS Google Scholar
• Davies MN, Sansom CE, Beazley C, Moss DS. A novel predictive technique for the MHC class II peptide-binding interaction. Mol Med. 2003;9(9–12):220–5.
  PubMed CAS Google Scholar
• Desmet J, Meersseman G, Boutonnet N, Pletinckx J, De Clercq K, Debulpaep M, et al. Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation. Proteins. 2005;58(1):53–69.
  Article PubMed CAS Google Scholar
• Lundegaard C, Hoof I, Lund O, Nielsen M. State of the art and challenges in sequence based T-cell epitope prediction. Immunome Res. 2010;6 Suppl 2:S3.
  Article PubMed Google Scholar
• Fonseca SG, Coutinho-Silva A, Fonseca LAM, Segurado AC, Moraes SL, Rodrigues H, et al. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS. 2006;20(18):2263–73.
  Article PubMed CAS Google Scholar
• Fonseca CT, Cunha-Neto E, Goldberg AC, Kalil J, de Jesus AR, Carvalho EM, et al. Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection. Clin Exp Immunol. 2005;142(3):539–47.
  PubMed CAS Google Scholar
• Veeraraghavan S, Renzoni EA, Jeal H, Jones M, Hammer J, Wells AU, et al. Mapping of the immunodominant T cell epitopes of the protein topoisomerase I. Ann Rheum Dis. 2004;63(8):982–7.
  Article PubMed CAS Google Scholar
• Iwai LK, Yoshida M, Sidney J, Shikanai-Yasuda MA, Goldberg AC, Juliano MA, et al. In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol Med. 2003;9(9–12):209–19.
  PubMed CAS Google Scholar
• Kapoerchan VV, Wiesner M, Hillaert U, Drijfhout JW, Overhand M, Alard P, et al. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol Immunol. 2010;47(5):1091–7.
  Article PubMed CAS Google Scholar
• Anthony DD, Lehmann PV. T-cell epitope mapping using the ELISPOT approach. Methods. 2003;29(3):260–9.
  Article PubMed CAS Google Scholar
• Mashishi T, Gray CM. The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes. Clin Chem Lab Med. 2002;40(9):903–10.
  Article PubMed CAS Google Scholar
• James EA, LaFond R, Durinovic-Bello I, Kwok W. Visualizing antigen specific CD4+ T cells using MHC class II tetramers. J Vis Exp. 2009;(25).
• Hu G-L, Okita DK, Conti-Fine BM. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects. J Thromb Haemost. 2004;2(11):1908–17.
  Article PubMed CAS Google Scholar
• Jones TD, Phillips WJ, Smith BJ, Bamford CA, Nayee PD, Baglin TP, et al. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII. J Thromb Haemost. 2005;3(5):991–1000.
  Article PubMed CAS Google Scholar
• Mond JJ, Vos Q, Lees A, Snapper CM. T cell independent antigens. Curr Opin Immunol. 1995;7(3):349–54.
  Article PubMed CAS Google Scholar
• Perini P, Facchinetti A, Bulian P, Massaro AR, Pascalis DD, Bertolotto A, et al. Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur Cytokine Netw. 2001;12(1):56–61.
  PubMed CAS Google Scholar
• Ben-Horin S, Mazor Y, Yanai H, Ron Y, Kopylov U, Yavzori M, et al. The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. Aliment Pharmacol Ther. 2012;35(6):714–22.
  Article PubMed CAS Google Scholar
• Sauerborn M, Brinks V, Jiskoot W, Schellekens H. Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends Pharmacol Sci. 2010;31(2):53–9.
  Article PubMed CAS Google Scholar
• Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci. 2005;14(1):246–8.
  Article PubMed CAS Google Scholar
• De Groot AS, McMurry J, Moise L. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. Curr Opin Pharmacol. 2008;8(5):620–6.
  Article PubMed Google Scholar
• Greenbaum JA, Andersen PH, Blythe M, Bui H-H, Cachau RE, Crowe J, et al. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit. 2007;20(2):75–82.
  Article PubMed CAS Google Scholar
• Giacò L, Amicosante M, Fraziano M, Gherardini PF, Ausiello G, Helmer-Citterich M, et al. B-Pred, a structure based B-cell epitopes prediction server. Adv Appl Bioinform Chem. 2012;5:11–21.
  PubMed Google Scholar
• Giese C, Lubitz A, Demmler CD, Reuschel J, Bergner K, Marx U. Immunological substance testing on human lymphatic micro-organoids in vitro. J Biotechnol. 2010;148(1):38–45.
  Article PubMed CAS Google Scholar
• Koren E, Zuckerman LA, Mire-Sluis AR. Immune responses to therapeutic proteins in humans–clinical significance, assessment and prediction. Curr Pharm Biotechnol. 2002;3(4):349–60.
  Article PubMed CAS Google Scholar
• Katsutani N, Yoshitake S, Takeuchi H, Kelliher JC, Couch RC, Shionoya H. Immunogenic properties of structurally modified human tissue plasminogen activators in chimpanzees and mice. Fundam Appl Toxicol. 1992;19(4):555–62.
  Article PubMed CAS Google Scholar
• Bellomi F, Muto A, Palmieri G, Focaccetti C, Dianzani C, Mattei M, et al. Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis. New Microbiol. 2007;30(3):241–6.
  PubMed CAS Google Scholar
• Braun A, Kwee L, Labow MA, Alsenz J. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res. 1997;14(10):1472–8.
  Article PubMed CAS Google Scholar
• Hermeling S, Schellekens H, Maas C, Gebbink MFBG, Crommelin DJA, Jiskoot W. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation. J Pharm Sci. 2006;95(5):1084–96.
  Article PubMed CAS Google Scholar
• Van Beers MMC, Sauerborn M, Gilli F, Brinks V, Schellekens H, Jiskoot W. Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice. Pharm Res. 2011;28(10):2393–402.
  Article PubMed Google Scholar
• Filipe V, Jiskoot W, Basmeleh AH, Halim A, Schellekens H, Filipe V. Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice. MAbs. 2012;5:4(6).
  Google Scholar
• Van Beers MMC, Sauerborn M, Gilli F, Hermeling S, Brinks V, Schellekens H, et al. Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta. J Immunol Methods. 2010;352(1–2):32–7.
  Article PubMed Google Scholar
• Ottesen JL, Nilsson P, Jami J, Weilguny D, Dührkop M, Bucchini D, et al. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia. 1994;37(12):1178–85.
  Article PubMed CAS Google Scholar
• Stewart TA, Hollingshead PG, Pitts SL, Chang R, Martin LE, Oakley H. Transgenic mice as a model to test the immunogenicity of proteins altered by site-specific mutagenesis. Mol Biol Med. 1989;6(4):275–81.
  PubMed CAS Google Scholar
• Lee HJ, Riley G, Johnson O, Cleland JL, Kim N, Charnis M, et al. In vivo characterization of sustained-release formulations of human growth hormone. J Pharmacol Exp Ther. 1997;281(3):1431–9.
  PubMed CAS Google Scholar
• Zwickl CM, Cocke KS, Tamura RN, Holzhausen LM, Brophy GT, Bick PH, et al. Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeys. Fundam Appl Toxicol. 1991;16(2):275–87.
  Article PubMed CAS Google Scholar
• Zwickl CM, Smith HW, Zimmermann JL, Wierda D. Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period. Arzneimittelforschung. 1995;45(4):524–8.
  PubMed CAS Google Scholar
• Center for Biologics Evaluation and Research. Meeting of the biological response modifiers advisory committe. July 15, Bethesda MD. Food and Drug Administration. 1999.
• Gunn H. Immunogenicity of recombinant human interleukin-3. Clin Immunol Immunopathol. 1997;83(1):5–7.
  Article PubMed CAS Google Scholar
• Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002;169(10):5595–600.
  PubMed CAS Google Scholar
• Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 1997;185(6):1113–22.
  Article PubMed CAS Google Scholar
• Madoiwa S, Yamauchi T, Hakamata Y, Kobayashi E, Arai M, Sugo T, et al. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A. J Thromb Haemost. 2004;2(5):754–62.
  Article PubMed CAS Google Scholar
• Madoiwa S, Yamauchi T, Kobayashi E, Hakamata Y, Dokai M, Makino N, et al. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A. J Thromb Haemost. 2009;7(5):811–24.
  Article PubMed CAS Google Scholar
• Fishwild DM, O’Donnell SL, Bengoechea T, Hudson DV, Harding F, Bernhard SL, et al. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol. 1996;14(7):845–51.
  Article PubMed CAS Google Scholar
• Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, et al. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci U S A. 1998;95(18):10797–802.
  Article PubMed CAS Google Scholar
• Mendez MJ, Green LL, Corvalan JR, Jia XC, Maynard-Currie CE, Yang XD, et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet. 1997;15(2):146–56.
  Article PubMed CAS Google Scholar
• Neeno T, Krco CJ, Harders J, Baisch J, Cheng S, David CS. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens: identification of antigenic epitopes. J Immunol. 1996;156(9):3191–5.
  PubMed CAS Google Scholar
• Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood. 2005;106(5):1565–73.
  Article PubMed CAS Google Scholar
• Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti J-C, Lanzavecchia A, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104–7.
  Article PubMed CAS Google Scholar
• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol. 2010;10(5):301–16.
  Article PubMed CAS Google Scholar
• Getts DR, Getts MT, McCarthy DP, Chastain EML, Miller SD. Have we overestimated the benefit of human(ized) antibodies? MAbs. 2010;2(6):682–94.
  Article PubMed Google Scholar
• Scott DW, De Groot AS. Can we prevent immunogenicity of human protein drugs? Ann Rheum Dis. 2010;69 Suppl 1:72–6.
  Article Google Scholar
• Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, Katano I, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol. 2009;21(7):843–58.
  Article PubMed CAS Google Scholar
• Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012;12(11):786–98.
  Article PubMed CAS Google Scholar